Floatz logo

Therapeutic Asset Ratings

1,553 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
cd19/bcma car t-cells
POEMS Syndrome
Zhejiang UniversityEarly P1C (39)
cd19/bcma car t-cells
Vasculitis
Zhejiang UniversityEarly P1C (39)
cd19/bcma-targeted car-t cells
Autoimmune Encephalitis (AE)
Tongji HospitalEarly P1C (39)
cd19/bcma-targeted car-t cells
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Tongji HospitalEarly P1C (39)
cd19/bcma-targeted car-t cells
Myasthenia Gravis (MG)
Tongji HospitalEarly P1C (39)
cd19/bcma-targeted car-t cells
Non-Hodgkin's Lymphoma Refractory
Zhejiang UniversityEarly P1C (39)
cd19/bcma-targeted car-t cells
Relapsing or Refractory Multiple Sclerosis (MS)
Tongji HospitalEarly P1C (39)
cd19/cd20/bcma car-t
Relapsed
Shanghai Cell Therapy Group Co.,LtdEarly P1C (39)
cd19/cd20/bcma car t cells
Non-Hodgkin Lymphoma, B-cell
Shanghai Cell Therapy Group Co.,LtdEarly P1C (39)
cd19 specific chimeric antigen receptor t cell
B Cell Leukemia
Nationwide Children's HospitalEarly P1C (39)
cd19 specific chimeric antigen receptor t cell
B-Cell Non-Hodgkin Lymphoma
Nationwide Children's HospitalEarly P1C (39)
cd19 specific chimeric antigen receptor t cell
Non-Hodgkin Lymphoma
Nationwide Children's HospitalEarly P1C (39)
Cd-Ga-102
Colorectal Cancer
Shanghai Changzheng HospitalEarly P1C (39)
cdh17 car-t
Gastric Cancer
Zhejiang UniversityEarly P1C (39)
cdh17 car-t
Multiple Cancer
Zhejiang UniversityEarly P1C (39)
cdh17 car-t
Pancreatic Ductal Adenocarcinoma
Zhejiang UniversityEarly P1C (39)
Cenobamate
Nervous System Disorder
Brigham and Women's HospitalEarly P1C (39)
Cerebrolysin
Basilar Artery Occlusion
University Hospital Sestre MilosrdniceEarly P1C (39)
Cerebrolysin
Brain Infarction
University Hospital Sestre MilosrdniceEarly P1C (39)
Chimeric Antigen Receptor Modified T Cells Infusion
CAR-T
Zhimin ZhaiEarly P1C (39)
Chimeric Antigen Receptor Modified T Cells Infusion
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
Shandong Qilu Cell Therapy Engineering Technology Co., LtdEarly P1C (39)
Chimeric Antigen Receptor Modified T Cells Infusion
DLBCL Activated B-Cell Type
Memorial Sloan Kettering Cancer CenterEarly P1C (39)
Chimeric Antigen Receptor Modified T Cells Infusion
Dlbcl-Ci
Memorial Sloan Kettering Cancer CenterEarly P1C (39)
Chimeric Antigen Receptor Modified T Cells Infusion
DLBCL Germinal Center B-Cell Type
Memorial Sloan Kettering Cancer CenterEarly P1C (39)
Chimeric Antigen Receptor Modified T Cells Infusion
HGBL
Memorial Sloan Kettering Cancer CenterEarly P1C (39)
Showing 326 to 350 of 1,553 assets
PreviousPage 14 of 63Next